Shanxi Zhendong Pharmaceutical Co.,Ltd (300158.SZ)
CNY 4.78
(-0.21%)
CNY 4.78
(-0.21%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 3.62 Billion | 3.72 Billion | 5.09 Billion | 4.84 Billion | 4.39 Billion | 3.41 Billion |
| Cost of Revenue | 1.79 Billion | 1.88 Billion | 2.05 Billion | 1.83 Billion | 1.54 Billion | 1.17 Billion |
| Gross Profit | 1.82 Billion | 1.83 Billion | 3.03 Billion | 3.01 Billion | 2.84 Billion | 2.24 Billion |
| Operating Expenses | 1.82 Billion | 1.94 Billion | 2.82 Billion | 2.66 Billion | 2.58 Billion | 2.13 Billion |
| Selling, General and Administrative Expenses | 1.57 Billion | 1.63 Billion | 2.44 Billion | 2.32 Billion | 2.28 Billion | 1.88 Billion |
| Research and Development Expenses | 191.01 Million | 178.1 Million | 218.72 Million | 136.19 Million | 145.31 Million | 123.17 Million |
| Other Expenses | 91.85 Million | 639.91 Thousand | -5.44 Million | -3.36 Million | 328.61 Thousand | -3.17 Million |
| Cost and Expenses | 3.65 Billion | 3.83 Billion | 4.88 Billion | 4.49 Billion | 4.13 Billion | 3.31 Billion |
| Operating Income | -29.98 Million | -5.92 Million | 3.12 Billion | 326.22 Million | 191.09 Million | -83.91 Million |
| Interest Expense | 1.2 Million | 13.77 Million | 19.62 Million | 20.85 Million | 26.12 Million | 29.4 Million |
| Income Tax Expense | 10.17 Million | 51.71 Million | 506.49 Million | 69.28 Million | 54.38 Million | 63.43 Million |
| Earnings before Tax | -37.69 Million | -5.28 Million | 3.11 Billion | 322.85 Million | 191.42 Million | -87.09 Million |
| Net Income | -43.98 Million | -51.29 Million | 2.61 Billion | 262.02 Million | 142.76 Million | -147.44 Million |
| Earnings Per Share Basic | -0.04 | -0.05 | 2.55 | 0.26 | 0.14 | -0.14 |
| Earnings Per Share Diluted | -0.04 | -0.05 | 2.55 | 0.26 | 0.14 | -0.14 |
| Weighted Average Shares Outstanding | 1.02 Billion | 1.02 Billion | 1.02 Billion | 1.02 Billion | 1.02 Billion | 1.03 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.02 Billion | 1.02 Billion | 1.02 Billion | 1.02 Billion | 1.02 Billion | 1.03 Billion |
| Gross Margin | 0.50 | 0.49 | 0.60 | 0.62 | 0.65 | 0.66 |
| EBIT Margin | 0.03 | 0.02 | 0.65 | 0.11 | 0.08 | 0.07 |
| Profit Margin | -0.01 | -0.01 | 0.51 | 0.05 | 0.03 | -0.04 |
| EBITDA | 94.75 Million | 157.99 Million | 3.26 Billion | 545.59 Million | 333.73 Million | 100 Million |
| Earnings Before Tax Margin | -0.01 | -0.00 | 0.61 | 0.07 | 0.04 | -0.02 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 762.82 Million | 724.47 Million | 782.13 Million | 3.62 Billion | 842.27 Million | 850.85 Million |
| Cost of Revenue | 354.66 Million | 325.44 Million | 434.91 Million | 1.79 Billion | 429.8 Million | 386.71 Million |
| Gross Profit | 408.15 Million | 399.02 Million | 347.21 Million | 1.82 Billion | 412.46 Million | 464.14 Million |
| Operating Expenses | 399.1 Million | 380.93 Million | 346.14 Million | 1.89 Billion | 492.29 Million | 483.41 Million |
| Selling, General and Administrative Expenses | 561.06 Million | 248.05 Million | 313.86 Million | - | 302.6 Million | 519.76 Million |
| Research and Development Expenses | 44.75 Million | 62.87 Million | 38.44 Million | - | 53.73 Million | 48.54 Million |
| Other Expenses | -206.7 Million | -2.92 Million | -1.29 Million | -7.7 Million | -7.12 Million | -1.48 Million |
| Cost and Expenses | 753.77 Million | 706.38 Million | 781.06 Million | 3.69 Billion | 922.1 Million | 870.12 Million |
| Operating Income | 12.63 Million | 12.13 Million | 32.28 Million | -29.98 Million | -41.72 Million | -16.84 Million |
| Interest Expense | 1.1 Million | 1.22 Million | 295.17 Thousand | 1.2 Million | 208.78 Thousand | 56.05 Thousand |
| Income Tax Expense | 2.54 Million | 4.01 Million | 8.64 Million | 10.17 Million | -5.11 Million | -1.98 Million |
| Earnings before Tax | 11 Million | 9.76 Million | 30.99 Million | -37.69 Million | -48.85 Million | -18.33 Million |
| Net Income | 9.46 Million | 7.55 Million | 23.1 Million | -43.98 Million | -43.1 Million | -15.41 Million |
| Earnings Per Share Basic | 0.01 | 0.01 | 0.02 | - | -0.04 | -0.02 |
| Earnings Per Share Diluted | 0.01 | 0.01 | 0.02 | - | -0.04 | -0.02 |
| Weighted Average Shares Outstanding | 1 Billion | 1 Billion | 1.02 Billion | 1.02 Billion | 1.19 Billion | 1.02 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1 Billion | 1 Billion | 1.02 Billion | 1.02 Billion | 1.19 Billion | 1.02 Billion |
| Gross Margin | 0.54 | 0.55 | 0.44 | 0.50 | 0.49 | 0.55 |
| EBIT Margin | 0.02 | 0.04 | 0.02 | - | -0.08 | -0.01 |
| Profit Margin | 0.01 | 0.01 | 0.03 | -0.01 | -0.05 | -0.02 |
| EBITDA | 12.11 Million | 29.73 Million | 17.4 Million | - | -65.67 Million | -12.75 Million |
| Earnings Before Tax Margin | 0.02 | 0.02 | 0.04 | -0.01 | -0.05 | -0.02 |
BEKE
GALD
CHOICEIN
NATHUEC
300631
TKPHF